Salivary gland mucoepidermoid carcinoma is a clinically, morphologically and genetically heterogeneous entity: A clinicopathological study of 40 cases with emphasis on grading, histological variants and presence of the t(11;19) translocation

Histopathology

Volumn 58, Issue 4, 2011, Pages 557-570

  Schwarz, Stephan ^a   Stiegler, Clemens ^b   Müller, Maximilian ^a   Ettl, Tobias ^b   Brockhoff, Gero ^b   Zenk, Johannes ^a   Agaimy, Abbas ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

Grading; Mucoepidermoid carcinoma; Salivary gland; T(11; 19); Variant

Indexed keywords

ADENOSQUAMOUS CARCINOMA; ADULT; ARTICLE; CANCER GRADING; CANCER SURVIVAL; CELL STRUCTURE; CELL TYPE; CHROMOSOME TRANSLOCATION 11; CHROMOSOME TRANSLOCATION 19; CLINICAL ARTICLE; DISEASE COURSE; EOSINOPHIL; FEMALE; GENETIC HETEROGENEITY; GENETIC VARIABILITY; GROUPS BY AGE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; MUCOSA CELL; OVERALL SURVIVAL; PRIORITY JOURNAL; REPRODUCIBILITY; SALIVARY GLAND CARCINOMA; SQUAMOUS CELL;

ANALYSIS OF VARIANCE; CARCINOMA, MUCOEPIDERMOID; CHROMOSOMES, HUMAN, PAIR 11; CHROMOSOMES, HUMAN, PAIR 19; CONFIDENCE INTERVALS; DIAGNOSIS, DIFFERENTIAL; FEMALE; GERMANY; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM STAGING; PROGNOSIS; SALIVARY GLAND NEOPLASMS; SALIVARY GLANDS; TIME FACTORS; TRANSLOCATION, GENETIC;

EID: 79952713252     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2011.03777.x     Document Type: Article

References (30)

1. Goode RK, El-Naggar AK. Mucoepidermoid carcinoma. In Barnes L, Eveson JW, Reichart P, Sidransky D eds. World Health Organization classification of tumour. Pathology and genetics of head and neck tumours. Lyon: IARC Press, 2005; 219-220.
2. Eveson JW, Cawson RA. Salivary gland tumours. A review of 2410 cases with particular reference to histological types, site, age and sex distribution. J. Pathol. 1985; 146; 51-58.
3. de Araujo VC, de Sousa SO, Carvalho YR, de Araujo NS. Application of immunohistochemistry to the diagnosis of salivary gland tumors. Appl. Immunohistochem. Mol. Morphol. 2000; 8; 195-202.
4. Rizkalla H, Toner M. Necrotizing sialometaplasia versus invasive carcinoma of the head and neck: the use of myoepithelial markers and keratin subtypes as an adjunct to diagnosis. Histopathology 2007; 51; 184-189.
5. Ettl T, Schwarz S, Kleinsasser N, Hartmann A, Reichert TE, Driemel O. Overexpression of EGFR and absence of C-KIT expression correlate with poor prognosis in salivary gland carcinomas. Histopathology 2008; 53; 567-577.
6. Subramaniam MM, Ng SB, Seah SB, Anuar D, Soong R, Lee VK. Molecular characterization of dedifferentiated mucoepidermoid carcinoma of the trachea using laser microdissection-based TP53 mutation analysis. Histopathology 2009; 55; 472-475.
7. Auclair PL, Goode RK, Ellis GL. Mucoepidermoid carcinoma of intraoral salivary glands. Evaluation and application of grading criteria in 143 cases. Cancer 1992; 69; 2021-2030.
8. Goode RK, Auclair PL, Ellis GL. Mucoepidermoid carcinoma of the major salivary glands: clinical and histopathologic analysis of 234 cases with evaluation of grading criteria. Cancer 1998; 82; 1217-1224.
9. Luna MA. Salivary mucoepidermoid carcinoma: revisited. Adv. Anat. Pathol. 2006; 13; 293-307.
10. Nance MA, Seethala RR, Wang Y et al. Treatment and survival outcomes based on histologic grading in patients with head and neck mucoepidermoid carcinoma. Cancer 2008; 113; 2082-2089.
11. Aro K, Leivo I, Makitie AA. Management and outcome of patients with mucoepidermoid carcinoma of major salivary gland origin: a single institution's 30-year experience. Laryngoscope 2008; 118; 258-262.
12. Brandwein MS, Ivanov K, Wallace DI et al. Mucoepidermoid carcinoma: a clinicopathologic study of 80 patients with special reference to histological grading. Am. J. Surg. Pathol. 2001; 25; 835-845.
13. Nakayama T, Miyabe S, Okabe M et al. Clinicopathological significance of the CRTC3-MAML2 fusion transcript in mucoepidermoid carcinoma. Mod. Pathol. 2009; 22; 1575-1581.
14. O'Neill ID. t(11;19) translocation and CRTC1-MAML2 fusion oncogene in mucoepidermoid carcinoma. Oral Oncol. 2009; 45; 2-9.
15. Behboudi A, Enlund F, Winnes M et al. Molecular classification of mucoepidermoid carcinomas-prognostic significance of the MECT1-MAML2 fusion oncogene. Genes Chromosom. Cancer 2006; 45; 470-481.
16. Martins C, Cavaco B, Tonon G, Kaye FJ, Soares J, Fonseca I. A study of MECT1-MAML2 in mucoepidermoid carcinoma and Warthin's tumor of salivary glands. J. Mol. Diagn. 2004; 6; 205-210.
17. Bullerdiek J, Haubrich J, Meyer K, Bartnitzke S. Translocation t(11;19)(q21;p13.1) as the sole chromosome abnormality in a cystadenolymphoma (Warthin's tumor) of the parotid gland. Cancer Genet. Cytogenet. 1988; 35; 129-132.
18. Tirado Y, Williams MD, Hanna EY, Kaye FJ, Batsakis JG, El-Naggar AK. CRTC1/MAML2 fusion transcript in high grade mucoepidermoid carcinomas of salivary and thyroid glands and Warthin's tumors: implications for histogenesis and biologic behavior. Genes Chromosom. Cancer 2007; 46; 708-715.
19. Okabe M, Miyabe S, Nagatsuka H et al. MECT1-MAML2 fusion transcript defines a favorable subset of mucoepidermoid carcinoma. Clin. Cancer Res. 2006; 12; 3902-3907.
20. Miyabe S, Okabe M, Nagatsuka H et al. Prognostic significance of p27Kip1, Ki-67, and CRTC1-MAML2 fusion transcript in mucoepidermoid carcinoma: a molecular and clinicopathologic study of 101 cases. J. Oral Maxillofac. Surg. 2009; 67; 1432-1441.
21. Meer S, Altini M. CK7+/CK20- immunoexpression profile is typical of salivary gland neoplasia. Histopathology 2007; 51; 26-32.
22. Schwarz S, Bier J, Driemel O et al. Losses of 3p14 and 9p21 as shown by fluorescence in situ hybridization are early events in tumorigenesis of oral squamous cell carcinoma and already occur in simple keratosis. Cytometry A 2008; 73; 305-311.
23. Milanes-Yearsley M, Hammond ME, Pajak TF et al. Tissue micro-array: a cost and time-effective method for correlative studies by regional and national cancer study groups. Mod. Pathol. 2002; 15; 1366-1373.
24. Lennerz JK, Perry A, Mills JC, Huettner PC, Pfeifer JD. Mucoepidermoid carcinoma of the cervix: another tumor with the t(11;19)-associated CRTC1-MAML2 gene fusion. Am. J. Surg. Pathol. 2009; 33; 835-843.
25. Lueck NE, Robinson RA. High levels of expression of cytokeratin 5 are strongly correlated with poor survival in higher grades of mucoepidermoid carcinoma. J. Clin. Pathol. 2008; 61; 837-840.
26. Brannon RB, Willard CC. Oncocytic mucoepidermoid carcinoma of parotid gland origin. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 2003; 96; 727-733.
27. Weinreb I, Seethala RR, Perez-Ordonez B, Chetty R, Hoschar AP, Hunt JL. Oncocytic mucoepidermoid carcinoma: clinicopathologic description in a series of 12 cases. Am. J. Surg. Pathol. 2009; 33; 409-416.
28. Foschini MP, Marucci G, Eusebi V. Low-grade mucoepidermoid carcinoma of salivary glands: characteristic immunohistochemical profile and evidence of striated duct differentiation. Virchows Arch. 2002; 440; 536-542.
29. Williamson JD, Simmons BH, el-Naggar A, Medeiros LJ. Mucoepidermoid carcinoma involving Warthin tumor. A report of five cases and review of the literature. Am. J. Clin. Pathol. 2000; 114; 564-570.
30. Bell D, Luna MA. Warthin adenocarcinoma: analysis of 2 cases of a distinct salivary neoplasm. Ann. Diagn. Pathol. 2009; 13; 201-207.